|
Home Patient Education Organization Consultations Diabetes Hypertension Lipid disorder Thyroid Arthritis Fever Weight Reduction Asthma over view Jaundice Hepatitis A Sleep disorders Cardiac markers CT MRI Xray Discounts Lab tests Free camps For Patients For Doctors Pharma companies For students For schools Life Insurance Alerts Visitor page Donate About us Disclaimer Feed back |
[Up] [Management drug therapy] [Management foot problems] [Management kidney problems] [Management eye complications] [Management Hypertension] [Management lipid disorders] [Management hypoglycemia] [Management neuropathy]
Management Lipid abnormalities in diabetics
Lipids include 'bad' and 'good' cholesterol / lipids.
Bad lipids include:
 |
Triglycerides. |
 |
Very low density lipoprotein (VLDL) cholesterol. |
 |
Low density lipoprotein (LDL) cholesterol. |
 |
Total cholesterol. |
Good lipid include:
 |
High density lipoprotein (HDL) cholesterol. |
 |
A high level of bad and /or low level of good lipid lead to Atherosclerosis (hardening of arteries due to lipid deposits). |
 |
Dyslipidemia is a term used to describe abnormal lipid levels with altered lipid ratios .(LDL / HDL; Cholesterol / HDL) |
Management of lipid disorder (dyslipidemia) includes:
 |
To achieve 'Target levels' of lipids for optimum control. |
 |
Good 'Glycemic control' (sugar control). This helps to decrease the level of dyslipidemia, especially the raised serum Triglycerides levels; HDL-C (good cholesterol) may increase; extent of oxidant stress and degree of glycation and oxidation of proteins decreases. |
 |
Life style modification. |
 |
Weight reduction, if overweight. |
 |
Regular exercise schedule; can help to increase HDL-C levels. |
 |
Smoking and alcohol intake to be actively discouraged. |
 |
Diet control. |
Diet control
 |
Diet therapy is central to optimizing lipid levels. |
 |
Total fat intake < 20% of total calorie intake. |
 |
Ensure correct essential fatty acid (EFA) intake, with near optimal omega6 / omega3 (w6/w3) ratio (5:1). |
 |
'Invisible' fat in the food must be taken into account. |
 |
Cooking oils should be a judicious mix of PUFAs, MUFAs and saturated fats; no one oil is beneficial; cooking oils should contribute < 6% total energy intake. |
 |
Foods rich in saturated fats and high in n6 fatty acids should be reduced. |
 |
Foods rich in n3 fatty acids may be beneficial. |
 |
Diet and life style modifications should be given an adequate trial for at least 3-6 months before commencing specific lipid lowering drug therapy. |
Target levels of lipids for optimum control.
OPTIMUM MANAGEMENT
TEST PARAMETER |
GOOD |
FAIR |
POOR |
Total Cholesterol mg/100ml |
<200 |
200-240 |
>240 |
HDL-Cholesterol mg/100ml |
>45 |
35-45 |
<35 |
LDL-Cholesterol mg/100ml |
<100 |
100-129 |
>130 |
Triglycerides mg/100ml |
<150 |
150-200 |
>200 |
Drug therapy.
 |
Different classes of drugs are available having effect on various lipids to varying degree. The therapy is individualized depending upon the lipid pattern. |
 |
Anti-oxidants such as Vitamin-E, Vitamin-C etc. may play a significant role by decreasing LDL oxidation. |
 |
Fish oils rich in n3 fatty acids have been shown to help in correcting dyslipidemia. |
Lipid abnormalities in diabetics |